HOME Top Market Reports Contract Research Organizations (CROs) Services Market by Type (Preclinical, Clinical Research, Laboratory), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceutical, Biopharmaceutical & Medical Device Companies) - Global Forecast to 2021

Contract Research Organizations (CROs) Services Market by Type (Preclinical, Clinical Research, Laboratory), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceutical, Biopharmaceutical & Medical Device Companies) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: October 2016
Report Code: PH 4672

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global contract research organizations services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021 to reach USD 41.86 Billion by 2021. Growing R&D expenditure, increased outsourcing of R&D activities, growing demand for outsourcing analytical testing and clinical trial services, and increase in the number of clinical trials are expected to propel the growth of this market. However, increasing regulatory pressure on CROs can hinder their market growth to a certain extent.

In this report, the global contract research organizations services market is segmented on the basis of services, therapeutic area, end user, and region. On the basis of services, the market is segmented into early-phase development services, clinical research services, laboratory services, and consulting services. The clinical research services accounted for the largest share of the CRO services market in 2015, owing to growing number of biosimilars and biologics by pharmaceutical and biopharmaceutical companies, increase in R&D activities, and growing number of clinical trials.

Based on therapeutic area, the CRO services market is segmented into oncology, central nervous system, cardiovascular, respiratory, diabetes, and other therapeutic areas. Similarly, on the basis of end user, the market is segmented into pharmaceutical and biopharmaceutical companies, medical device companies, and academic institutes.

Geographically, the global CRO services market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded a major share of the global contract research organizations services market. Factors such as high quality standards in the pharmaceutical industry, rapid growth in the biosimilars and biologics market, rising demand for outsourcing of services by pharmaceutical and biopharmaceutical companies, and increase in clinical trial activities in this region are contributing to the large share of North America. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the fast-growing pharmaceutical industry, favorable government policies, increasing number of pharmaceutical companies establishing manufacturing facilities, and lower cost for clinical trials in this region.

Some of the prominent players in the global contract research organizations services market include Quintiles Transnational Holdings Inc. (U.S.), Laboratory Corporation Of America Holdings (U.S.), Pharmaceutical Product Development, LLC (U.S.), PAREXEL International Corporation (U.S.), ICON Plc (Ireland), PRA Health Sciences, Inc. (U.S.), InVentiv Health Inc. (U.S.), Charles River Laboratories International Inc. (U.S.), INC Research Holdings Inc. (U.S.), and Wuxi PharmaTech (Cayman) Inc. (China).

Target Audience:

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Medical Device Manufacturing Companies
  • Government Associations
  • Market Research and Consulting Firms
  • Academic and Research Institutes
  • Venture Capitalists and Investors

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

The research report categorizes the global contract research organizations services market into the following segments and subsegments:

Global Contract Research Organizations Services Market, by Service Type

  • Early-phase Development Services
    • Discovery Studies
    • Chemistry, Manufacturing, and Control
    • Preclinical
      • Pharmacokinetics/Pharmacodynamics (PK/PD)
      • Toxicology Testing
      • Other Preclinical Services
  • Clinical Research Services
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Laboratory Services
    • Bioanalytical Testing
    • Analytical Testing
      • Physical Characterization
      • Stability Testing
      • Batch-release Testing
      • Raw Materials Testing
      • Other Analytical Testing
  • Consulting Services

Global Contract Research Organizations Services Market, by Therapeutic Area

  • Oncology
  • Central Nervous System
  • Cardiovascular
  • Respiratory
  • Diabetes
  • Other Therapeutic Areas

Global Contract Research Organizations Services Market, by End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Medical Device Companies
  • Academic Institutes

Global Contract Research Organizations Services Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Rest of the World (RoW)
    • Latin America
    • Middle East and Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Service Analysis

  • Service matrix, which gives a detailed comparison of the service portfolios of each company

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific CRO services market into South Korea, Australia, New Zealand, and others
  • Further breakdown of the Rest of Europe CRO services market into Belgium, Russia, Netherlands, Switzerland, and others
  • Further breakdown of the Rest of Latin America CRO services market into Brazil, Argentina, and Mexico

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 20)
    1.1 Objectives of The Study
    1.2 contract research organizations services Market Definition
    1.3 contract research organizations services Market Scope
           1.3.1 contract research organizations services Market Covered
           1.3.2 Years Considered for The Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 23)
    2.1 Research Approach
           2.1.1 Secondary Sources
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Sources
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 contract research organizations services Market Size Estimation
    2.3 contract research organizations services Market Breakdown and Data Triangulation
    2.4 contract research organizations services Market Share Estimation
    2.5 Assumptions for The Study

3 Executive Summary (Page No. - 31)

4 Premium Insights (Page No. - 37)
    4.1 Contract Research Organizations: Market Overview
    4.2 Asia-Pasific: Contract Research Organizations Market, By Clinical Research Service (2015)
    4.3 Contract Research Organizations Services Market: Geographic Growth Opportunities
    4.4 Contract Research Organizations Services Market: Geographic Mix
    4.5 Contract Research Organizations Services Market: Developing vs Developed Countries/Regions

5 Market Overview (Page No. - 41)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Key Market Drivers
                    5.2.1.1 Growing R&D Expenditure
                    5.2.1.2 Growth in Outsourcing of R&D Activities
                    5.2.1.3 Increasing Demand for Outsourcing of Analytical Testing and Clinical Trial Services
                    5.2.1.4 Increasing Number of Clinical Trials
           5.2.2 Key Market Restraints
                    5.2.2.1 Regulatory Pressure on Contract Research Organizations
           5.2.3 Key Market Opportunities
                    5.2.3.1 Growing Biosimilars and Biologics Markets
                    5.2.3.2 Rising Demand for Specialized Testing Services
           5.2.4 Key Challenges
                    5.2.4.1 Growing Competition in The Contract Research Organizations Industry
                    5.2.4.2 Regulatory Pressure on Pharma and Medical Device Manufacturers to Drive More Detailed Analysis of Drugs and Devices
                    5.2.4.3 Shortage of Skilled Professionals
    5.3 Industry Trends
           5.3.1 Growing Consolidation in The Cro Industry
           5.3.2 Globalization of Clinical Trials

6 Global Contract Research Organizations Services Market, By Type of Service (Page No. - 54)
    6.1 Introduction
    6.2 Clinical Research Services
           6.2.1 Phase I Clinical Research Services
           6.2.2 Phase II Clinical Research Services
           6.2.3 Phase III Clinical Research Services
           6.2.4 Phase IV Clinical Research Services
    6.3 Early-Phase Development Services
           6.3.1 Discovery Studies
           6.3.2 Chemistry, Manufacturing, & Control (CMC)
           6.3.3 Preclinical Services
                    6.3.3.1 Pharmacokinetics/Pharmacodynamics (PK/PD)
                    6.3.3.2 Toxicology Testing Services
                    6.3.3.3 Other Preclinical Services
    6.4 Laboratory Services
           6.4.1 Bioanalytical Testing Services
           6.4.2 Analytical Testing Services
                    6.4.2.1 Physical Characterization
                    6.4.2.2 Raw Material Testing
                    6.4.2.3 Batch-Release Testing
                    6.4.2.4 Stability Testing
                    6.4.2.5 Other Analytical Testing Services
    6.5 Consulting Services

7 Global Contract Research Organizations Services Market, By Therapeutic Area (Page No. - 84)
    7.1 Introduction
    7.2 Oncology
    7.3 Central Nervous System (CNS)
    7.4 Cardiovascular
    7.5 Respiratory
    7.6 Diabetes
    7.7 Other Therapeutic Areas

8 Global Contract Research Organizations Services Market, By End User (Page No. - 95)
    8.1 Introduction
    8.2 Pharmaceutical and Biopharmaceutical Companies
    8.3 Medical Device Companies
    8.4 Academic Institutes

9 Global Contract Research Organizations Services Market, By Region (Page No. - 102)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 U.K.
           9.3.3 France
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 Rest of Europe (RoE)
    9.4 Asia-Pacific
           9.4.1 China
           9.4.2 Japan
           9.4.3 India
           9.4.4 Rest of Asia-Pacific (RoAPAC)
    9.5 Rest of The World (RoW)
           9.5.1 Latin America
           9.5.2 Middle East and Africa

10 Competitive Landscape (Page No. - 193)
     10.1 Overview
     10.2 Contract Research Organizations Services Market Share Analysis
     10.3 Competitive Situations and Trends
             10.3.1 Agreements, Collaborations, Joint Ventures, and Partnerships
             10.3.2 Service Launches
             10.3.3 Expansions
             10.3.4 Mergers and Acquisitions
             10.3.5 Service Enhancements

11 Company Profiles (Page No. - 203)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     11.1 Introduction
     11.2 Quintiles Transnational Holdings Inc.
     11.3 Laboratory Corporation of America Holdings
     11.4 Paraxel International Corporation
     11.5 Pra Health Sciences, Inc.
     11.6 Pharmaceutical Product Development, LLC.
     11.7 Icon PLC
     11.8 Inventiv Health Inc.
     11.9 Charles River Laboratories International, Inc.
     11.10 Inc Research Holdings, Inc.
     11.11 Wuxi Pharmatech (Cayman) Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 237)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Other Developments
     12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.5 Available Customizations
     12.6 Introducing RT: Real-Time Market Intelligence
     12.7 Related Reports


List of Tables (217 Tables)

Table 1 Business Expenditure on R&D in The Pharmaceutical Industry, By Country/Region, 2005–2011 (USD Billion)
Table 2 Expenditure on R&D By Function, Phrma Member Companies (2013)
Table 3 Activities Outsourced in The Pharmaceutical Industry (2014 vs 2015)
Table 4 Increasing Demand for Outsourcing of Analytical Testing and Clinical Trial Services to Drive Market Growth
Table 5 Regulatory Pressure on Contract Research Organizations to Restrain Market Growth
Table 6 Clinical Studies for Biologic & Biosimlar Molecules (2016)
Table 7 Growing Biosimilars and Biologics Markets to Provide Significant Growth Opportunities
Table 8 Overview of Regulatory Guidelines
Table 9 Regulatory Pressure on Pharma and Medical Device Manufactures to Provide More Detailed Analysis of Drugs & Devices is A Major Challenge in The Market
Table 10 Major Acquisitions in Cro Industry (2013–2016)
Table 11 Global Contract Research Organizations Services Market Size, By Type of Service, 2014–2021 (USD Million)
Table 12 Global Contract Research Organizations Services Market Size, By Country, 2014–2021 (USD Million)
Table 13 Global Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 14 Global Clinical Research Services Market Size, By Country, 2014–2021 (USD Million)
Table 15 Phase I Clinical Research Services Market Size, By Country, 2014–2021 (USD Million)
Table 16 Global Phase II Clinical Research Services Market Size, By Country, 2014–2021 (USD Million)
Table 17 Global Phase III Clinical Research Services Market Size, By Country, 2014–2021 (USD Million)
Table 18 Global Phase IV Clinical Research Services Market Size, By Country, 2014–2021 (USD Million)
Table 19 Global Early-Phase Development Services Market Size, By Country, 2014–2021 (USD Million)
Table 20 Global Discovery Studies Market Size, By Country, 2014–2021 (USD Million)
Table 21 Global Chemistry, Manufacturing, & Control (CMC) Services Market Size, By Country, 2014–2021 (USD Million)
Table 22 Global Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 23 Global Preclinical Services Market Size, By Country, 2014–2021 (USD Million)
Table 24 Global Pharmacokinetics/Pharmacodynamics Market Size, By Country, 2014–2021 (USD Million)
Table 25 Global Toxicology Testing Services Market Size, By Country, 2014–2021 (USD Million)
Table 26 Global Other Preclinical Services Market Size, By Country, 2014–2021 (USD Million)
Table 27 Global Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 28 Global Laboratory Services Market Size, By Country, 2014–2021 (USD Million)
Table 29 Global Bioanalytical Testing Services Market Size, By Country, 2014–2021 (USD Million)
Table 30 Global Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 31 Global Analytical Testing Services Market Size, By Country, 2014–2021 (USD Million)
Table 32 Global Physical Characterization Services Market Size, By Country, 2014–2021 (USD Million)
Table 33 Global Raw Material Testing Services Market Size, By Country, 2014–2021 (USD Million)
Table 34 Global Batch-Release Testing Services Market Size, By Country, 2014–2021 (USD Million)
Table 35 Global Stability Testing Services Market Size, By Country, 2014–2021 (USD Million)
Table 36 Global Other Analytical Testing Services Market Size, By Country, 2014–2021 (USD Million)
Table 37 Global Consulting Services Market Size, By Country, 2014–2021 (USD Million)
Table 38 Global Number of Clinical Trials in Different Therapeutic Areas, 2016
Table 39 Global Contract Research Organizations Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 40 Global Contract Research Organizations Services Market Size for Oncology, By Country, 2014–2021 (USD Million)
Table 41 Global Contract Research Organizations Services Market Size for CNS, By Country, 2014–2021 (USD Million)
Table 42 Global Contract Research Organizations Services Market Size for Cardiovascular, By Country, 2014–2021 (USD Million)
Table 43 Global Contract Research Organizations Services Market Size for Respiratory, By Country, 2014–2021 (USD Million)
Table 44 Global Contract Research Organizations Services Market Size for Diabetes, By Country, 2014–2021 (USD Million)
Table 45 Global Contract Research Organizations Services Market Size for Other Therapeutic Areas, By Country, 2014–2021 (USD Million)
Table 46 Global Contract Research Organizations Services Market Size, By End User, 2014–2021 (USD Million)
Table 47 Global Contract Research Organizations Services Market Size for Pharmaceutical & Biopharmaceutical Companies, By Country, 2014–2021 (USD Million)
Table 48 Global Contract Research Organizations Services Market Size for Medical Device Companies, By Country, 2014–2021 (USD Million)
Table 49 Global Contract Research Organizations Services Market Size for Academic Institutes, By Country, 2014–2021 (USD Million)
Table 50 Global Contract Research Organizations Services Market Size, By Region, 2014–2021 (USD Million)
Table 51 North America: Contract Research Organizations Services Market Size, By Country, 2014–2021 (USD Million)
Table 52 North America: Contract Research Organizations Services Market Size, By Service, 2014–2021 (USD Million)
Table 53 North America: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 54 North America: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 55 North America: Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 56 North America: Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 57 North America: Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 58 North America: CROs Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 59 North America: CROs Market Size, By End User, 2014–2021 (USD Million)
Table 60 Total Number of Clinical Trials in The U.S. (2016)
Table 61 U.S.: Contract Research Organizations Services Market Size, By Service, 2014–2021 (USD Million)
Table 62 U.S.: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 63 U.S.: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 64 U.S.: Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 65 U.S.: Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 66 U.S.: Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 67 U.S.: Contract Research Organizations Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 68 U.S.: Contract Research Organizations Services Market Size, By End User, 2014–2021 (USD Million)
Table 69 Number of Clinical Trials for Small Molecules, Biosimilars, and Medical Devices in Canada (2016)
Table 70 R&D Expenditure in Canada in Different Phases, 2013 & 2014
Table 71 Canada: Contract Research Organizations Services Market Size, By Service, 2014–2021 (USD Million)
Table 72 Canada: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 73 Canada: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 74 Canada: Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 75 Canada: Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 76 Canada: Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 77 Canada: Contract Research Organizations Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 78 Canada: Contract Research Organizations Services Market Size, By End User, 2014–2021 (USD Million)
Table 79 Europe: Pharmaceutical R&D Expenditure, By Country, 2012 & 2014
Table 80 Europe: Contract Research Organizations Services Market Size, By Country, 2014–2021 (USD Million)
Table 81 Europe: Contract Research Organizations Services Market Size, By Service, 2014–2021 (USD Million)
Table 82 Europe: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 83 Europe: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 84 Europe: Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 85 Europe: Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 86 Europe: Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 87 Europe: Contract Research Organizations Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 88 Europe: Contract Research Organizations Services Market Size, By End User, 2014–2021 (USD Million)
Table 89 Pharmaceutical Industry R&D Investments in Germany (2010-2014)
Table 90 Biotechnology Industry in Germany (2009-2014)
Table 91 Germany: CRO Services Market Size, By Service, 2014–2021 (USD Million)
Table 92 Germany: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 93 Germany: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 94 Germany: Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 95 Germany: Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 96 Germany: Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 97 Germany: CROs Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 98 Germany: CRO Services Market Size, By End User, 2014–2021 (USD Million)
Table 99 U.K.: CRO Services Market Size, By Service, 2014–2021 (USD Million)
Table 100 U.K.: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 101 U.K.: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 102 U.K.: Clinical Research Services Market Size, By Type, 2014–2019 (USD Million)
Table 103 U.K.: Laboratory Services Market Size, By Type, 2014–2019 (USD Million)
Table 104 U.K.: Analytical Testing Services Market Size, By Type, 2014–2019 (USD Million)
Table 105 U.K.: CRO Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 106 U.K.: CRO Services Market Size, By End User, 2014–2021 (USD Million)
Table 107 France: CRO Services Market Size, By Service, 2014–2021 (USD Million)
Table 108 France: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 109 France: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 110 France: Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 111 France: Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 112 France: Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 113 France: CRO Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 114 France: CRO Services Market Size, By End User, 2014–2021 (USD Million)
Table 115 Pharmaceutical R&D Investments in Italy, 2009-2014
Table 116 Clinical Trials Per Drug Typology (2013 & 2014)
Table 117 Clinical Trials Per Therapeutic Area (2013& 2014)
Table 118 Italy: CRO Services Market Size, By Service, 2014–2021 (USD Million)
Table 119 Italy: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 120 Italy: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 121 Italy: Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 122 Italy: Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 123 Italy: Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 124 Italy: CRO Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 125 Italy: CRO Services Market Size, By End User, 2014–2021 (USD Million)
Table 126 Spain: CRO Services Market Size, By Service, 2014–2021 (USD Million)
Table 127 Spain: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 128 Spain: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 129 Spain: Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 130 Spain: Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 131 Spain: Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 132 Spain: CRO Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 133 Spain: CRO Services Market Size, By End User, 2014–2021 (USD Million)
Table 134 Pharmaceutical R&D Expenditure in Belgium (2010-2014)
Table 135 Pharmaceutical Production and R&D Expenditure in Denmark, 2012-2014
Table 136 RoE: CRO Services Market Size, By Service, 2014–2021 (USD Million)
Table 137 RoE: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 138 RoE: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 139 RoE: Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 140 RoE: Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 141 RoE: Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 142 RoE: CRO Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 143 RoE: CRO Services Market Size, By End User, 2014–2021 (USD Million)
Table 144 Total Number of Clinical Trials in APAC, By Therapeutic Area,2016
Table 145 Asia-Pacific: CRO Services Market Size, By Country, 2014–2021 (USD Million)
Table 146 Asia-Pacific: CRO Services Market Size, By Service, 2014–2021 (USD Million)
Table 147 Asia-Pacific: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 148 Asia-Pacific: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 149 Asia-Pacific: Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 150 Asia-Pacific: Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 151 Asia-Pacific: Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 152 Asia-Pacific: CRO Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 153 Asia-Pacific: CRO Services Market Size, By End User, 2014–2021 (USD Million)
Table 154 Cost of Clinical Trials: U.S. & China (2012)
Table 155 China: CRO Services Market Size, By Service, 2014–2021 (USD Million)
Table 156 China: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 157 China: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 158 China: Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 159 China: Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 160 China: Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 161 China: CRO Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 162 China: CRO Services Market Size, By End User, 2014–2021 (USD Million)
Table 163 Japan: CRO Services Market Size, By Service, 2014–2021 (USD Million)
Table 164 Japan: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 165 Japan: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 166 Japan: Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 167 Japan: Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 168 Japan: Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 169 Japan: CRO Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 170 Japan: CRO Services Market Size, By End User, 2014–2021 (USD Million)
Table 171 India: CRO Services Market Size, By Service, 2014–2021 (USD Million)
Table 172 India: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 173 India: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 174 India: Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 175 India: Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 176 India: Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 177 India: CRO Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 178 India: CRO Services Market Size, By End User, 2014–2021 (USD Million)
Table 179 Rest of Asia-Pacific: CRO Services Market Size, By Service, 2014–2021 (USD Million)
Table 180 Rest of Asia-Pacific: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 181 Rest of Asia-Pacific: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 182 Rest of Asia-Pacific: Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 183 Rest of Asia-Pacific: Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 184 Rest of Asia-Pacific: Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 185 Rest of Asia-Pacific: CRO Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 186 Rest of Asia-Pacific: CRO Services Market Size, By End User, 2014–2021 (USD Million)
Table 187 RoW: CRO Services Market Size, By Region, 2014–2021 (USD Million)
Table 188 RoW: CRO Services Market Size, By Service, 2014–2021 (USD Million)
Table 189 RoW: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 190 RoW: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 191 RoW: Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 192 RoW: Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 193 RoW: Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 194 RoW: CRO Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 195 RoW: CRO Services Market Size, By End User, 2014–2021 (USD Million)
Table 196 Latin America: CRO Services Market Size, By Service, 2014–2021 (USD Million)
Table 197 Latin America: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 198 Latin America: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 199 Latin America: Clinical Research Services Market Size, By Type, 2014–2012 (USD Million)
Table 200 Latin America: Laboratory Services Market Size, By Type, 2014–2012 (USD Million)
Table 201 Latin America: Analytical Testing Services Market Size, By Type, 2014–2012 (USD Million)
Table 202 Latin America: CRO Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 203 Latin America: CRO Services Market Size, By End User, 2014–2021 (USD Million)
Table 204 Middle East and Africa: CRO Services Market Size, By Service, 2014–2021 (USD Million)
Table 205 Middle East and Africa: Early-Phase Development Services Market Size, By Type, 2014–2021 (USD Million)
Table 206 Middle East and Africa: Preclinical Services Market Size, By Type, 2014–2021 (USD Million)
Table 207 Middle East and Africa: Clinical Research Services Market Size, By Type, 2014–2021 (USD Million)
Table 208 Middle East and Africa: Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 209 Middle East and Africa: Analytical Testing Services Market Size, By Type, 2014–2021 (USD Million)
Table 210 Middle East and Africa: CRO Services Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 211 Middle East and Africa: CRO Services Market Size, By End User, 2014–2021 (USD Million)
Table 212 Growth Strategy Matrix, 2013–2016
Table 213 Agreements, Collaborations, Joint Ventures, and Partnerships, 2013-2016
Table 214 Service Launches, 2013-2016
Table 215 Expansions, 2013-2016
Table 216 Mergers and Acquisitions, 2013-2016
Table 217 Service Enhancements, 2013-2016


List of Figures (47 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Drivers, Restraints, Opportunities, Challenges, and Trends of The Global Contract Research Organizations Services Market
Figure 7 Contract Research Organizations Services Market Size, By Service, 2016 vs 2021 (USD Million)
Figure 8 Contract Research Organizations Services Market Size, By Therapeutic Area, 2016 vs 2021 (USD Million)
Figure 9 Global Contract Research Organizations Services Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 10 Geographic Snapshot of The Contract Research Organizations Services Market
Figure 11 Growth Strategy Matrix of The Top 5 Players in The Global Contract Research Organizations Services Market
Figure 12 Increasing Demand of Outsourcing Analytical Testing and Clinical Trials to Drive Market Growth During The Forecast Period
Figure 13 Phase III Clinical Research Services Dominated The APAC Clinical Research Services Market in 2015
Figure 14 The U.S. Dominated The Global Contract Research Organizations Services Market in 2015
Figure 15 North America to Dominate The Contract Research Organizations Market in 2016
Figure 16 China to Register The Highest Growth During The Forecast Period
Figure 17 Contract Research Organizations Services Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Total Number of Registered Studies (2005-2016)
Figure 19 Number of Clinical Trials, By Country (2016)
Figure 20 Total Number of New Molecular Entity (NME) Approvals & New Biologics License Applications (BLA) (2005–2015)
Figure 21 Growing Consolidation in The CRO Industry and Globalization of Clinical Trials are The Leading Industry Trends
Figure 22 Biologic Medicines in Development, By Therapeutic Area, 2013
Figure 23 Phases of Drug Discovery Studies
Figure 24 Total Number of Clinical Trials for Oncology (2016)
Figure 25 Pharmaceutical & Biopharmaceutical Companies to Dominate The CROs Market During The Forecast Period
Figure 26 R&D Spending of Phrma Member Companies, 1980–2015
Figure 27 Clinical Studies on Medical Devices (2016)
Figure 28 Geographic Snapshot (2016): APAC Markets are Emerging as New Growth Hotspots
Figure 29 Total Number of Clinical Trials: Global vs North America (2016)
Figure 30 North America: Contract Research Organizations Market Snapshot
Figure 31 Pharmaceutical R&D Expenditure in The U.S. (1990-2014)
Figure 32 Pharmaceutical R&D Expenditure in Europe (2010-2014)
Figure 33 APAC: Contract Research Organizations Market Snapshot
Figure 34 Clinical Trial Phases Conducted in Australia, 2013
Figure 35 Agreements, Collaborations, Joint Ventures, and Partnerships–Key Growth Strategies Pursued By Market Players Between 2013 & 2016
Figure 36 Global Contract Research Organizations Market Share, By Key Player, 2015
Figure 37 Battle for Market Share: Agreements, Collaborations, Joint Ventures, and Partnerships Was The Key Strategy
Figure 38 Geographical Revenue Mix of The Top 4 Players
Figure 39 Quintiles Transnational Holdings Inc.: Company Snapshot
Figure 40 Laboratory Corporation of America Holdings: Company Snapshot
Figure 41 Paraxel International Corporation: Company Snapshot
Figure 42 Pra Health Sciences, Inc.: Company Snapshot
Figure 43 Icon PLC: Company Snapshot
Figure 44 Inventiv Health Inc.: Company Snapshot
Figure 45 Charles River Laboratories International, Inc.: Company Snapshot
Figure 46 Inc Research Holdings, Inc.: Company Snapshot
Figure 47 Wuxi Pharmatech (Cayman) Inc.: Company Snapshot

The global CRO services market is projected to reach USD 41.86 Billion by 2021 from USD 29.29 Billion in 2016, at a CAGR of 7.4% from 2016 to 2021. The contract research organizations services market is expected to witness significant growth in the coming years due to the increased demand for outsourcing of analytical testing and clinical trial services majorly by pharmaceutical, biopharmaceutical, and medical device companies.

Factors such as growing R&D expenditure, increased outsourcing of R&D activities, and increase in the number of clinical trials are the primary growth drivers for the global CRO services market. Increasing regulatory pressure on the CROs is expected to hinder the growth of this market. Growing competition in the CROs industry, regulatory pressure on pharma and medical device companies to drive detailed analysis of drugs and devices, and shortage of skilled professionals are the major challenges for this industry.

The report analyzes the CRO services market by service, therapeutic area, end user, and region. On the basis of services, the global market is segmented into early-phase development services, clinical research services, laboratory services, and consulting services. In 2015, the clinical research services segment accounted for the largest share of the contract research organizations services market. The large share of this segment can primarily be attributed to the growing number of biosimilars and biologics by pharmaceutical and biopharmaceutical companies, increase in R&D activities, and increase in the number of clinical trials. Based on type of therapeutic area, the market is segmented into oncology, central nervous system, cardiovascular, respiratory, diabetes, and other therapeutic areas. Based on end user, the contract research organizations services market is segmented into pharmaceutical and biopharmaceutical companies, medical device companies, and academic institutes. The pharmaceutical and biopharmaceutical companies segment is estimated to dominate the market primarily due to their robust pipeline; growing R&D expenditure; and increasing outsourcing of early-phase development, clinical research, and laboratory testing services to boost profit margins, avoid high capital expenditure, and reduce the time of drug development.

In 2015, North America dominated the contract research organizations services market, followed by Europe. The high-quality standards in the pharmaceutical industry, rapid growth in the biosimilars and biologics market, rising demand for outsourcing services by pharmaceutical and biopharmaceutical companies, and increase in the number of clinical trial activities are factors driving the growth of this market. On the other hand, the Asia-Pacific region is expected to witness the highest growth rate during the forecast period. The fast-growing pharmaceutical industry in these regions, favorable government policies, increasing number of pharmaceutical companies establishing manufacturing facilities, and lower cost for clinical trials are key market drivers in this region.

Contract Research Organizations (CROs) Services Market

The global contract research organizations services market is characterized by the presence of a large number of players. Amidst intense market competition, major players are continuously focusing on achieving higher market shares through agreements, collaborations, joint ventures, and partnerships; new service launches; mergers and acquisitions; and expansions. In 2015, the market was dominated by five major players, together accounting for a share of around 45%-50%. Quintiles Transnational Holdings Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Pharmaceutical Product Development, LLC (U.S.), PAREXEL International Corporation (U.S.), and Icon Plc (Ireland) led the market. Some of the other major players in this market include PRA Health Sciences, Inc. (U.S.), InVentiv Health Inc. (U.S.), Charles River Laboratories International Inc. (U.S.), INC Research Holdings Inc. (U.S.), and Wuxi PharmaTech (Cayman) Inc. (China).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Pharmaceuticals Markets on KnowledgeStore
Request Demo